To view or add a comment, sign in Ozempic (Semaglutide): The Healthcare Standard for T2DM & Obesity is Here The dual epidemic of Type 2 Diabetes (T2DM) and Obesity continues to challenge patient outcomes
Stratified analyses showed no differences between subgroups
Hair shedding linked to GLP-1 use is usually telogen effluvium, a temporary shift in the hair growth cycle that often improves once weight stabilizes and nutrient needs are met
Tirzepatide injections were no longer listed as in shortage, while dulaglutide, semaglutide, and liraglutide remained constrained, with availability varying by presentation
For a complete pricing breakdown see our guide to how much BPC-157 and TB-500 cost in 2026 and what each tier includes
Again, it only gets better from here